Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma

Eileen M. O'Reilly*, Diletta Barone, Devalingam Mahalingam, Tanios Bekaii-Saab, Spencer H. Shao, Julie Wolf, Molly Rosano, Silva Krause, Donald A. Richards, Kenneth H. Yu, James M. Roach, Keith T. Flaherty, David P. Ryan

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science